{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T14:06:42Z","timestamp":1761919602775},"reference-count":33,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,12,31]],"date-time":"2016-12-31T00:00:00Z","timestamp":1483142400000},"content-version":"vor","delay-in-days":1401,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurolog\u00eda"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1016\/j.nrl.2012.03.014","type":"journal-article","created":{"date-parts":[[2012,7,28]],"date-time":"2012-07-28T02:47:58Z","timestamp":1343443678000},"page":"65-72","source":"Crossref","is-referenced-by-count":58,"title":["Estudio del efecto del tratamiento con inmunoglobulinas por v\u00eda intravenosa en la neuromielitis \u00f3ptica"],"prefix":"10.1016","volume":"28","author":[{"given":"M.J.","family":"Magraner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Coret","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Casanova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nrl.2012.03.014_bib0005","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S1474-4422(07)70216-8","article-title":"The spectrum of neuromyelitis optica","volume":"6","author":"Wingerchuk","year":"2007","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.nrl.2012.03.014_bib0010","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/ana.21524","article-title":"Immunoglobulins and complement in postmortem multiple sclerosis tissue","volume":"65","author":"Barnett","year":"2009","journal-title":"Ann Neurol"},{"key":"10.1016\/j.nrl.2012.03.014_bib0015","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1093\/brain\/awf151","article-title":"A role of humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica","volume":"125","author":"Lucchinetti","year":"2002","journal-title":"Brain"},{"key":"10.1016\/j.nrl.2012.03.014_bib0020","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1084\/jem.20050304","article-title":"IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel","volume":"202","author":"Lennon","year":"2005","journal-title":"J Exp Med"},{"key":"10.1016\/j.nrl.2012.03.014_bib0025","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1016\/S0140-6736(04)17551-X","article-title":"A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis","volume":"364","author":"Lennon","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.nrl.2012.03.014_bib0030","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1093\/brain\/awl371","article-title":"Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis","volume":"130","author":"Roemer","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.nrl.2012.03.014_bib0035","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1212\/01.WNL.0000289761.64862.ce","article-title":"Pathogenic potential of IgG binding to water channel extracellular domain in neuromyelitis optica","volume":"69","author":"Hinson","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.nrl.2012.03.014_bib0040","doi-asserted-by":"crossref","first-page":"5730","DOI":"10.4049\/jimmunol.181.8.5730","article-title":"Functional consequences of neuromyelitis optica-IgG astrocyte interactions on blood-brain barrier permeability and granulocyte recruitment","volume":"181","author":"Vincent","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.nrl.2012.03.014_bib0045","first-page":"440","article-title":"Intravenous immunoglobulin in neurological disease: a specialist review","volume":"72","author":"Wiles","year":"2008","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.nrl.2012.03.014_bib0050","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/0140-6736(93)92000-J","article-title":"Infusion of Fcg fragments for the treatment of children with acute immune thrombocytopenic purpura","volume":"342","author":"Debr\u00e9","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.nrl.2012.03.014_bib0055","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/S0161-5890(97)00091-6","article-title":"Effect of whole and fractionated intravenous immunoglobulin on complement in vitro","volume":"34","author":"Mollnes","year":"1991","journal-title":"Mol Immunol"},{"key":"10.1016\/j.nrl.2012.03.014_bib0060","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.4049\/jimmunol.144.4.1387","article-title":"A view of the human idiotypic repertoire: electronmicroscopic and immunologic analyses of spontaneous idiotype anti-idiotype dimers in pooled human IgG","volume":"144","author":"Roux","year":"1990","journal-title":"J Immunol"},{"key":"10.1016\/j.nrl.2012.03.014_bib0065","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1017\/S0317167100053932","article-title":"Devic's neuromyelitis optica treated with intravenous gamma globulin (IVIG)","volume":"31","author":"Bakker","year":"2004","journal-title":"Can J Neurol Sci"},{"key":"10.1016\/j.nrl.2012.03.014_bib0070","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.2169\/internalmedicine.46.0217","article-title":"Intermittent intravenous immunoglobulin successfully prevents relapses of neuromyelitis optica","volume":"46","author":"Okada","year":"2007","journal-title":"Intern Med"},{"key":"10.1016\/j.nrl.2012.03.014_bib0075","unstructured":"National Institute of Health guidelines. [consultado 2010]. Disponible en: http:\/\/www.clinicaltrials.gov\/ct2\/info\/"},{"key":"10.1016\/j.nrl.2012.03.014_bib0080","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1007\/s00415-007-0509-8","article-title":"Revised diagnostic criteria for neuromyelitis \u00f3ptica (NMO): application in a serie of suspected patients","volume":"254","author":"Saiz","year":"2007","journal-title":"J Neurol"},{"key":"10.1016\/j.nrl.2012.03.014_bib0085","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1212\/01.wnl.0000216139.44259.74","article-title":"Revised diagnostic criteria for neuromyelitis optica","volume":"66","author":"Wingerchuk","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.nrl.2012.03.014_bib0090","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0022-1759(01)00492-6","article-title":"Description of a sensitive and reproducible method for the detection of oligoclonal IgM bands","volume":"258","author":"Villar","year":"2001","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.nrl.2012.03.014_bib0095","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1001\/archneur.62.4.574","article-title":"Early differential diagnosis of multiple sclerosis using a new oligoclonal band test","volume":"62","author":"Villar","year":"2005","journal-title":"Arch Neurol"},{"key":"10.1016\/j.nrl.2012.03.014_bib0100","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1212\/WNL.38.2.180","article-title":"MRI in the diagnosis of MS: a prospective study with comparison of clinical evaluation, evoked potentials, oligoclonal banding, and CT","volume":"38","author":"Paty","year":"1988","journal-title":"Neurology"},{"key":"10.1016\/j.nrl.2012.03.014_bib0105","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1212\/01.wnl.0000314832.24682.c6","article-title":"CNS aquaporin-4 autoimmunity in children","volume":"71","author":"McKeon","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.nrl.2012.03.014_bib0110","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1212\/01.WNL.0000159399.81861.D5","article-title":"An open label study of the effects of rituximab in neuromyelitis optica","volume":"64","author":"Cree","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.nrl.2012.03.014_bib0115","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1001\/archneur.65.11.noc80069","article-title":"Treatment of neuromyelitis optica with rituximab","volume":"65","author":"Jacob","year":"2008","journal-title":"Arch Neurology"},{"key":"10.1016\/j.nrl.2012.03.014_bib0120","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1212\/WNL.51.4.1219","article-title":"Devic's neuromyelitis optica: a prospective study of seven patients treated with prednisone and azathioprine","volume":"51","author":"Mandler","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.nrl.2012.03.014_bib0125","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1001\/archneur.63.7.957","article-title":"Study of mitoxantrone for the treatment of recurrent neuromyelitis optica (Devic disease)","volume":"63","author":"Weinstock-Guttman","year":"2006","journal-title":"Arch Neurol"},{"key":"10.1016\/j.nrl.2012.03.014_bib0130","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1212\/01.wnl.0000324422.69067.e7","article-title":"Four new cases of therapy-related acute promyelocytic leukemia after mitoxantrone","volume":"71","author":"Bosca","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.nrl.2012.03.014_bib0135","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1212\/WNL.58.5.824","article-title":"Intrathecal IgM synthesis in neurologic diseases: Relationship with disability in MS","volume":"58","author":"Villar","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.nrl.2012.03.014_bib0140","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1212\/01.wnl.0000284600.80782.d5","article-title":"Neuromyelitis optica-IgG in childhood inflammatory demyelinating CNS disorders","volume":"70","author":"Banwell","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.nrl.2012.03.014_bib0145","doi-asserted-by":"crossref","first-page":"3072","DOI":"10.1093\/brain\/awn240","article-title":"Antibody to aquaporin-4 in the long-term course of neuromyelitis optica","volume":"131","author":"Jarius","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.nrl.2012.03.014_bib0150","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1093\/brain\/119.4.1067","article-title":"Intravenous immunoglobulin treatment (IVIg) in chronic inflammatory demyelinating polyneuropathy (CIDP): a double-blind placebo-controlled cross-over study","volume":"119","author":"Hahn","year":"1996","journal-title":"Brain"},{"key":"10.1016\/j.nrl.2012.03.014_bib0155","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1002\/ana.410410615","article-title":"Clinical trial of plasma exchange and high-dose intravenous immunoglobulin in myasthenia gravis. Myasthenia Gravis Clinical Study Group","volume":"41","author":"Gajdos","year":"1997","journal-title":"Ann Neurol"},{"key":"10.1016\/j.nrl.2012.03.014_bib0160","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s00415-008-3004-y","article-title":"IVIg in other autoimmune neurological disorders: current status and future prospects","volume":"255","author":"Dalakas","year":"2008","journal-title":"J Neurol"},{"key":"10.1016\/j.nrl.2012.03.014_bib0165","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1111\/j.1468-1331.2008.02246.x","article-title":"EFNS Guidelines for the use of intravenous immunoglobuline in treatment of neurological diseases","volume":"15","author":"Elovaara","year":"2008","journal-title":"Eur J Neurol"}],"container-title":["Neurolog\u00eda"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0213485312000849?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0213485312000849?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,24]],"date-time":"2023-06-24T18:48:55Z","timestamp":1687632535000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0213485312000849"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["S0213485312000849"],"URL":"https:\/\/doi.org\/10.1016\/j.nrl.2012.03.014","relation":{},"ISSN":["0213-4853"],"issn-type":[{"value":"0213-4853","type":"print"}],"subject":[],"published":{"date-parts":[[2013,3]]}}}